NatWest Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-4,657
| Closed | -$728K | – | 366 |
|
|
2015
Q3 | $728K | Buy |
+4,657
| New | +$728K | 0.02% | 225 |
|
|
2015
Q2 | – | Sell |
-4,725
| Closed | -$819K | – | 442 |
|
|
2015
Q1 | $819K | Buy |
4,725
+1,057
| +29% | +$183K | 0.01% | 248 |
|
|
2014
Q4 | $679 | Buy |
3,668
+366
| +11% | +$68 | 0.01% | 266 |
|
|
2014
Q3 | $547 | Buy |
+3,302
| New | +$547 | ﹤0.01% | 337 |
|
|
2014
Q1 | – | Sell |
-18,099
| Closed | -$2.41M | – | 719 |
|
|
2013
Q4 | $2.41M | Buy |
18,099
+3,456
| +24% | +$459K | 0.06% | 250 |
|
|
2013
Q3 | $1.7M | Sell |
14,643
-6,699
| -31% | -$778K | 0.05% | 289 |
|
|
2013
Q2 | $1.97M | Buy |
+21,342
| New | +$1.97M | 0.03% | 326 |
|